当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2013]IndividualizedTreatment of Chronic Hepatitis B
—— 作者:J.l.Hou 时间:2013-06-13
阅读数:
416
简介:Hepatitis B virus (HBV) affects more than 350 million people worldwide and is responsible for more than 1 million deaths from end-stage liver diseases annually, especially in the Asia-Pacific region with high endemicity. Suppression of HBV DNA to undetectable levels with antiviral therapy has been shown to significantly slow down disease progression.
请登录后查看详细内容
标签:
热点聚焦
热点聚焦
乙肝
发表评论
全部评论